 |
EU crisis spells more pain for drugmakersDrugmakers are counting the cost of the deepening euro zone crisis, with further austerity-driven price cuts expected in important European markets, including Italy and France, said experts. Growing alarm at multiple government-imposed cut More… |
Drugmakers chase new markets as US, Europe flopAs sales of big-brand medicines in the United States and Europe falter, Western drug companies have new targets in their sights - the emerging wealthy middle classes of China, India and Russia. And such a drive into new areas of double-dig More… |
